Manju Sengar

Homi Bhabha National Institute — India

Medicine · Health Sciences

28h-index4.5kcitations375works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(95), Acute Myeloid Leukemia Research(60), Chronic Lymphocytic Leukemia Research(58), Acute Lymphoblastic Leukemia research(53), Economic and Financial Impacts of Cancer(35)

Publications374 total

Attrition Rates in Multiple Myeloma - A Report from indian Patients at A Tertiary Cancer Center
Indian Journal of Hematology and Blood Transfusion·2025Open Access
Multiple Myeloma in Young Adults—Insights From a Tertiary Care Cancer Centre in India
eJHaem·2025Open Access
Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.
Blood·2025Open Access
Baseline characteristics, serological and measurable residual disease responses and outcomes in newly diagnosed multiple myeloma patients not planned for autologous stem cell transplant; Results from a prospective randomised study using MRD guided therapy
Blood·2025Open Access
Provincialising Global Oncology
BMJ Global Health·2025Open Access
Case report: Ovariohysterectomy, post-surgical complications and its management in a Labrador-Spitz female dog
International Journal of Advanced Biochemistry Research·2025Open Access
314P Health record digitization using AI-powered ambient clinical intelligence solutions in low-middle income country to reduce physician burden and improve quality of documentation
ESMO Real World Data and Digital Oncology·2025Open Access
Subcutaneous immunotherapy—a wolf in sheep's clothing?
The Lancet Oncology·2025
Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050
Blood Global Hematology·2025· 1 citedOpen Access
Clinical Characteristics and Long Term Outcomes of POEMS Syndrome from a Tertiary Care Cancer Center
Clinical Lymphoma Myeloma & Leukemia·2025
Clinical Profile, Treatment Patterns, Outcomes and Predictors of Survival in AL Amyloidosis: A Retrospective Study from a Tertiary Cancer Center
Clinical Lymphoma Myeloma & Leukemia·2025
Detectable Peripheral Blood Measurable Residual Disease (PBMRD) is Strongly Associated with Early Progression in Newly Diagnosed Multiple Myeloma (NDMM)
Clinical Lymphoma Myeloma & Leukemia·2025
Minimal Residual Disease in Newly Diagnosed Multiple Myeloma Patients not Planned for upfront Autologous Stem Cell transplant: Patient Disposition and MRD Outcomes from a Prospective Clinical Trial
Clinical Lymphoma Myeloma & Leukemia·2025
Patterns of Use, Outcomes and Tolerance to Daratumumab in Multiple Myeloma: A Single-Centre Retrospective Study
Clinical Lymphoma Myeloma & Leukemia·2025
404 | CLINICAL RELEVANCE OF PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE ASSESSMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER INITIAL THERAPY: A PROSPECTIVE STUDY
Hematological Oncology·2025Open Access
Economic modelling to inform pricing for LMICs of immune checkpoint inhibitors in advanced PD-L1-high non-small cell lung cancer.
Journal of Clinical Oncology·2025· 1 cited
Correlation of Gastroduodenoscopic Findings With Histopathological Diagnosis of Gastroduodenal Biopsy
Cureus·2025Open Access
Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines
JNCI Journal of the National Cancer Institute·2025· 1 citedOpen Access
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Blood Cancer Journal·2025Open Access
Forecasting optimal treatments in relapsed/refractory mature T‐ and <scp>NK</scp>‐cell lymphomas: A global <scp>PETAL</scp> Consortium study
British Journal of Haematology·2025· 2 cited
page 1 of 19Next →

Frequent Co-authors

Bhausaheb Bagal(15), Hasmukh Jain(14), Prashant Tembhare(12), Richard Sullivan(11), Navin Khattry(11), Sumeet Gujral(11), Christopher M. Booth(10), Nikhil Patkar(10), Hari Menon(9), Papagudi Ganesan Subramanian(9), C.S. Pramesh(8), Girish Chinnaswamy(7), Verna Vanderpuye(7), Gaurav Chatterjee(7), Dhanalaxmi Shetty(7), Lingaraj Nayak(7), Avinash Bonda(7), Rajendra Badwe(6), Adam Fundytus(6), Wilma M. Hopman(6)